LeonaBio, Inc. (LONA)
NASDAQ: LONA · Real-Time Price · USD
9.76
+0.16 (1.67%)
Jul 13, 2026, 4:00 PM EDT - Market closed
LeonaBio Market Cap
LeonaBio has a market cap or net worth of $91.68 million as of July 13, 2026. Its market cap has increased by 674.99% in one year.
Market Cap
91.68M
Enterprise Value
24.69M
1-Year Change
674.99%
Ranking
Category
Stock Price
$9.76
Market Cap Chart
Since September 18, 2020, LeonaBio's market cap has decreased from $527.32M to $91.68M, a decrease of -82.61%. That is a compound annual growth rate of -25.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 91.68M | 207.08% |
| Dec 31, 2025 | 29.86M | 31.60% |
| Dec 31, 2024 | 22.69M | -75.47% |
| Dec 29, 2023 | 92.47M | -22.89% |
| Dec 30, 2022 | 119.92M | -75.36% |
| Dec 31, 2021 | 486.68M | -56.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biomea Fusion | 95.44M |
| Adicet Bio | 92.72M |
| Pelthos Therapeutics | 92.28M |
| Alps Group | 91.74M |
| Rein Therapeutics | 91.18M |
| Cardiff Oncology | 90.93M |
| OKYO Pharma | 88.69M |
| NeurAxis | 88.42M |